Skip to main content
Equibles

Edward C. Saltzman

Board Member

Nurix Therapeutics, Inc. (NRIX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Nurix Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get NRIX alerts

About Edward C. Saltzman

Edward C. Saltzman is recorded as Board Member at Nurix Therapeutics, Inc. (NRIX) since September 12, 2022. Nurix Therapeutics, Inc. reported in an 8-K filed September 14, 2022 that Edward C. Saltzman was appointed director, effective September 12, 2022. Nurix Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Nurix Therapeutics, Inc. includes Arthur T. Sands (CEO and Board Member), Hans van Houte (CFO), Stefani Wolff (COO) and 7 others.

“On September 12, 2022, the board of directors (the "Board") of Nurix Therapeutics, Inc. (the "Company"), following a recommendation from the Nominating and Corporate Governance Committee of the Board, appointed Edward C. Saltzman to serve as a director of the Company and as a member of the Compensation Committee of the Board (the "Compensation Committee") and the Development Advisory Committee of the Board (the "Development Advisory Committee"), effective immediately.”
Nurix Therapeutics, Inc. Form 8-K, filed September 14, 2022 · Read the filing

Affiliation history

Company network

Leadership on record at Nurix Therapeutics, Inc.

Recent activity